Nutraceutical clinical trials in ASIA Pacific region

Nutraceutical clinical trials are steadily increasing in the Asia-Pacific region. The nutraceutical market in the Asia-Pacific is experiencing tremendous growth and is expected to expand further. The Asia-Pacific region, encompassing countries like Australia, India, Japan, and China, offers significant opportunities for the nutraceutical market due to its large population, rising disposable income, and growing focus […]

Read More →
Cosmetics registration process in Thailand

Cosmetic product registration in Thailand has become faster and more environmentally friendly since November 1, 2010, when the Thai FDA adopted a new online cosmetic product registration system. Thailand’s cosmetics business is expanding, offering a wide range of beauty and personal care products. Thailand established a comprehensive regulatory framework to ensure consumer safety while maintaining […]

Read More →
New drug registration process in south korea

As South Korea emerges as a focal point for new drugs, understanding the drug registration and approval process becomes crucial for those intending to market their products in the country. With a population that values advancements in healthcare, there’s a constant search for effective treatments and solutions in South Korea. The demand extends across numerous medical […]

Read More →
Why ASIA-PACIFIC Leads The World In Clinical Trials

The Asia-Pacific region, with over half of the global population, is becoming a growing popular spot for conducting clinical trials by offering lower trial costs, access to large patient pools, and a friendly regulatory environment. These distinguishing traits are increasing interest in medical device, pharmaceutical, and healthcare companies to shift their clinical trial locations to […]

Read More →
New Drug Registration and Approval Process In Thailand

The new drug registration process in Thailand is complex, but with careful planning, expertise, and assistance from regulatory consultants or legal professionals, it can be navigated more easily and efficiently. The market for new drugs in Thailand is growing steadily, with an increasing demand for innovative pharmaceutical products. The market for new drugs accounts for […]

Read More →
Healthcare business expansion in Asia-pacific region

Asia-Pacific is a top destination for growing healthcare companies, with the APAC Healthcare Analytics Market size projected to increase by USD 20.84 billion at a CAGR of 27.94% between 2023 and 2028. The region offers opportunities for several healthcare products, such as pharmaceuticals, medical devices, cosmetics, and nutraceuticals. As APAC continues to experience economic development […]

Read More →
Singapore for Your Healthcare Products Market

The Singaporean healthcare and pharmaceutical market presents a lucrative opportunity for businesses aiming to expand their reach. Singapore presents a compelling opportunity for producers and distributors of healthcare products due to its sophisticated infrastructure, highly regulated industry, and dense population. Situated at the crossroads of Asia, Singapore boasts a dynamic economy, world-class infrastructure, and a […]

Read More →
Import of IMPs & ancillaries for clinical trials

Importing Ancillaries and IMPs for clinical trials in the Asia-Pacific region presents numerous challenges. Navigating diverse regulatory landscapes, and logistical complexities, ensuring quality control, and managing timeliness and costs are critical hurdles. Effective risk mitigation strategies are essential for overcoming potential disruptions. Overall, addressing these challenges is vital for the successful execution of clinical trials […]

Read More →
Choosing Asia-Pacific For Your Clinical Trials: Strategic Insights

The Asia-Pacific region emerges as a pivotal player in the landscape of clinical trials. They offer unique advantages for conducting impactful research due to diverse populations, varied healthcare infrastructures, and a rich pool of treatment-naive patients. Over the past decade, there has been a notable shift in the global Phase I clinical trials scenario, with […]

Read More →
Pharma Out-Licensing Process Essentials: Key Steps and Strategies

Pharma out-licensing is a strategic approach where a pharmaceutical company licenses its assets, such as drugs or technologies, to external partners. The process and key steps of out-licensing are crucial for companies looking to expand their reach, enhance their product portfolios, and capitalize within the industry. This guide streamlines the out-licensing process, regardless of experience […]

Read More →